Joost Smolders, MD, PhD, Erasmus University Medical Center, Rotterdam, Netherlands, discusses the potential value of broad rim lesions in the understanding and management of multiple sclerosis. Dr Smolders highlights that these lesions could help to stratify patients for trials and inform treatment decisions. This interview took place at the 12th Congress of the European Academy of Neurology (EAN) in Geneva, Switzerland.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.